APLS icon

Apellis Pharmaceuticals

281 hedge funds and large institutions have $7B invested in Apellis Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 64 funds opening new positions, 79 increasing their positions, 108 reducing their positions, and 33 closing their positions.

Holders
281
Holders Change
+27
Holders Change %
+10.63%
% of All Funds
4.12%
Holding in Top 10
9
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-10%
% of All Funds
0.13%
New
64
Increased
79
Reduced
108
Closed
33
Calls
$379M
Puts
$133M
Net Calls
+$247M
Net Calls Change
+$11.8M
Name Market Value Shares Shares
Change
Shares
Change %
IA
301
Inspire Advisors
Idaho
-6,115 Closed
WAM
302
Wolverine Asset Management
Illinois
-6,100 Closed
CC
303
Corton Capital
Ontario, Canada
-6,083 Closed
AWM
304
Avior Wealth Management
Nebraska
-3,806 Closed
QL
305
Quarry LP
New York
-3,500 Closed
FAM
306
Fred Alger Management
New York
-2,949 Closed
SSA
307
Schonfeld Strategic Advisors
New York
-1,200 Closed
SC
308
Stephens Consulting
Michigan
-1,000 Closed
CA
309
Clearstead Advisors
Ohio
-900 Closed
National Bank of Canada
310
National Bank of Canada
Quebec, Canada
-393 Closed
GWM
311
Geneos Wealth Management
Colorado
-100 Closed
BAAM
312
Baker Avenue Asset Management
California
-18 Closed
LFG
313
Larson Financial Group
Missouri
-11 Closed
TWP
314
TFO Wealth Partners
Ohio
-2 Closed
Twin Tree Management
315
Twin Tree Management
Texas
UOC
316
UBS O'Connor
Illinois
MCM
317
Moore Capital Management
New York
GTC
318
Ghost Tree Capital
New York
JGC
319
J. Goldman & Co
New York
HM
320
Harvest Management
New York
ACM
321
Altium Capital Management
New York
Squarepoint
322
Squarepoint
New York
PI
323
PEAK6 Investments
Illinois
SSG
324
Summit Securities Group
New York
Capital Fund Management (CFM)
325
Capital Fund Management (CFM)
France